JOINDER to LETTER AgreementJoinder to Letter Agreement • January 9th, 2024 • 10X Capital Venture Acquisition Corp. III • Biological products, (no disgnostic substances)
This Joinder to Letter Agreement (this “Joinder”) is made this 9th day of January, 2024, by Osman Ahmed (the “Officer”), in respect of that certain Letter Agreement (the “Letter Agreement”), dated as of January 11, 2022, by and among 10X Capital SPAC Sponsor III LLC (the “Sponsor”), 10X Capital Venture Acquisition Corp. III (the “Company”), and each of the other parties thereto. Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to them in the Letter Agreement.
